AEON Biopharma (AEON)

• Market cap: $15.2M
• 1 day: 1.85%
• 5 days: 3.77%
• 1 month: 39.33%
• 3 months: 36.04%
• 6 months: 44.74%
• Year to date: -97.22%
• 1 year: -97.17%
• 5 years: -99.84%
• 10 years: -99.84%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5